Dirk Schadendorf

Publishes on Melanoma and MAPK Pathways, Cutaneous Melanoma Detection and Management, Cancer Immunotherapy and Biomarkers. 2.4k papers and 225.6k citations.

PubIndex Score98Top 2%How it's scored

🌟#8 Current Senior Leader in Melanoma and MAPK Pathways

2.4kPublications

225.6kTotal Citations

#8in Melanoma and MAPK Pathways

First publication: 1993First senior author: 1993

Melanoma and MAPK Pathways Cutaneous Melanoma Detection and Management Cancer Immunotherapy and Biomarkers Immunotherapy and Immune Responses CAR-T cell therapy research

Top publicationsby citations

Improved Survival with Vemurafenib in Melanoma with BRAF V600E Mutation

Paul B. Chapman, Grant A. McArthur, Axel Hauschild et al.|New England Journal of Medicine|2011

Cited by 7.7k

Nivolumab in Previously Untreated Melanoma without <i>BRAF</i> Mutation

Caroline Robert, Paolo A. Ascierto, Georgina V. Long et al.|New England Journal of Medicine|2014

Cited by 5.3k

Pooled Analysis of Long-Term Survival Data From Phase II and Phase III Trials of Ipilimumab in Unresectable or Metastatic Melanoma

Dirk Schadendorf, Jedd D. Wolchok|Journal of Clinical Oncology|2015

Cited by 2.1k

Adjuvant Dabrafenib plus Trametinib in Stage III<i>BRAF</i>-Mutated Melanoma

Georgina V. Long, John M. Kirkwood, Axel Hauschild et al.|New England Journal of Medicine|2017

Cited by 1.5k

A Cancer Cell Program Promotes T Cell Exclusion and Resistance to Checkpoint Blockade

Livnat Jerby‐Arnon, Charles H. Yoon, Parin Shah et al.|Cell|2018

Cited by 1.5k